4.5 Article

Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018

Journal

AMERICAN HEART JOURNAL
Volume 243, Issue -, Pages 103-109

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2021.09.009

Keywords

-

Funding

  1. American Heart Association
  2. Amgen
  3. AstraZeneca
  4. BristolMyers Squibb
  5. Merck
  6. Novartis
  7. Mentored Patient-Oriented Research Career Development Award through the National Heart, Lung, and Blood Institute [K23HL150159]
  8. Amarin Pharma, Inc
  9. Abbott
  10. NHLBI from the National Heart, Lung, and Blood Institute (NHLBI) [K23HL151744]
  11. American Heart Association [20IPA35310955]
  12. Mario Family Award
  13. Duke Chair's Award
  14. Translating Duke Health Award
  15. Bayer
  16. Galmed
  17. NIH

Ask authors/readers for more resources

The study examined trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. While hospitalizations for heart failure have been increasing since 2013, those for acute myocardial infarction and stroke have seen decreases or remained stable. In-hospital mortality rates have decreased for all three conditions during the study period.
Aim To determine the trends in hospitalizations for heart failure (HF), acute myocardial infarction (AMI), and stroke in the United States (US). Method and Results A retrospective analysis of the National Inpatient Sample weighted data between January 1, 2004 and December 31, 2018 which included hospitalized adults >= 18 years with a primary discharge diagnosis of HF, AMI, or stroke using International Classification of Diseases-9/10 administrative codes. Main outcomes were hospitalization for HF, AMI, and stroke per 1000 United States adults, length of stay, and in-hospital mortality. There were 33.4 million hospitalizations for HF, AMI, and stroke, with most being for HF (48%). After the initial decline in HF hospitalizations (5.3 hospitalizations/1000 US adults in 2004 to 4 hospitalizations/1000 US adults in 2013, P < .001), there was a progressive increase in HF hospitalizations between 2013 and 2018 (4.0 hospitalizations/1000 US adults in 2013 to 4.9 hospitalizations/1000 US adults in 2018; P < .001). Hospitalization for AMI decreased (3.1 hospitalizations/1000 US adults in 2004 to 2.5 hospitalizations/1000 US adults in 2010, P < .001) and remained stable between 2010 and 2018. There was no significant change for hospitalization for stroke between 2004 and 2011 (2.3 hospitalizations/1000 US adults in 2004 vs 2.3 hospitalizations per 1000 US adults in 2011, P = .614); however, there was a small but significant increase in hospitalization for stroke after 2011 that reached 2.5 hospitalizations/1000 US adults in 2018. Adjusted length of stay and in-hospital mortality decreased for HF, AMI, and stroke hospitalizations. Conclusions In contrast to the trend of AMI and stroke hospitalizations, a progressive increase in hospitalizations for HF has occurred since 2013. From 2004 to 2018, in-hospital mortality has decreased for HF, AMI, and stroke hospitalizations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available